# Efficacy and Safety of Dexamethasone Nanoparticles Eye Drops in Diabetic Macular Edema

> **NCT05343156** · PHASE2 · COMPLETED · sponsor: **Oculis** · enrollment: 144 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** Dexamethasone nanoparticles eye drops

## Key facts

- **NCT ID:** NCT05343156
- **Lead sponsor:** Oculis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-18
- **Primary completion:** 2019-03-28
- **Final completion:** 2019-03-28
- **Target enrollment:** 144 (ACTUAL)
- **Last updated:** 2022-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05343156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05343156, "Efficacy and Safety of Dexamethasone Nanoparticles Eye Drops in Diabetic Macular Edema". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05343156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*